MAY 7, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Losartan Potassium (Labeling)
U.S. Food and Drug Administration
This is an FDA supplemental approval action for losartan potassium labeling; it documents a regulatory decision but does not report clinical trial outcomes or efficacy data.